Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 194

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 194
---
 single Circular and Proxy Statement, as applicable, addressed to those Shareholders, unless contrary instructions have been
received. This procedure, which is commonly referred to as “householding,” reduces the amount of duplicate information that Shareholders receive and lowers printing and mailing costs for companies.

Certain brokerage firms may have instituted householding for beneficial owners of Securities held through brokerage firms. If your family has
multiple accounts holding Securities, you may have already received a householding notification from your broker. You may decide at any time to revoke your decision to household, and thereby receive multiple copies of proxy materials. If you wish to
opt out of this procedure and receive a separate set of proxy materials in the future, or if you are receiving multiple copies and would like to receive only one, you should contact your broker, trustee or other nominee or the Company at the address
and telephone number below. A separate copy of these materials will be promptly delivered upon request by writing to Repare Therapeutics Inc., 7171 Frederick-Banting, Building 2, Suite 270, St-Laurent,
Québec, Canada, or by telephone at (857) 412-7018.

123

WHERE YOU CAN FIND MORE INFORMATION

Investors and Shareholders may obtain free copies of this Circular and Proxy Statement and other documents that are filed or will be filed
with the SEC by the Company through the website maintained by the SEC at www.sec.gov, the Company’s website at www.reparerx.com. Financial information is provided in the Company’s comparative Financial Statements and management’s
discussion and analysis for its most recently completed financial year and its most recently completed interim period which are filed on SEDAR+ and EDGAR, and will be sent without charge to any Shareholders upon request by requesting them in writing
from the Company at 7171 Frederick-Banting, Building 2, Suite 270, St-Laurent, Québec, Canada, or by telephone at (857) 412-7018.

The auditor of the Company is Ernst & Young LLP, Independent Registered Public Accounting Firm, having an address at 900 Boulevard de
Maisonneuve Ouest, Bureau 2300, Montréal, QC H3A 0A8.

Our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with SEC on March
3, 2025, and our Quarterly Report on Form 10-Q for the quarter ended
September 30, 2025 are incorporated by reference herein